2-(Substituted-phenyl)amino-imidazoline derivatives

摘要

This invention relates to IP receptor antagonists selected from the group of compounds represented by Formula I: where: R<1 >is a group represented by formula (A), (B) or (C); <custom-character file="US20030229123A1-20031211-P00999.TIF" wi="151.6" he="8.4" id="custom-character-00001" alt="text missing or illegible when filed"/>d other substituents as defined in the specification, and their pharmaceutically acceptable <custom-character file="US20030229123A1-20031211-P00999.TIF" wi="151.6" he="8.4" id="custom-character-00002" alt="text missing or illegible when filed"/>ts or crystal forms thereof; and pharmaceutical compositions containing them; and methods <custom-character file="US20030229123A1-20031211-P00999.TIF" wi="151.6" he="8.4" id="custom-character-00003" alt="text missing or illegible when filed"/> their use as therapeutic agents.